CHANGE IN RATINGS
Activision Blizzard (ATVI Quote) upgraded at Goldman Sachs to Buy from Neutral based on attractive late-2009 game slate and reduced investor focus on music genre fatigue. See potential for positive EPS revisions as Q1 results and E3 show ease concerns. Priec target raised to $14 from $10. Bristol-Myers Squibb (BMY Quote) downgraded at Goldman Sachs to Neutral from Buy based on relative valuation and lower potential as a takeout candidate. See greater opportunity in other stocks within coverage universe. Price target trimmed to $23 from $25.
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |














